Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-091670
Filing Date
2025-06-30
Accepted
2025-06-30 16:45:06
Documents
2
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3966
2 EX-24 alec-ex24.htm EX-24 21188
  Complete submission text file 0000950170-25-091670.txt   26695
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Berkley Neil Lindsay (Reporting) CIK: 0002075298 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38792 | Film No.: 251092745